(Q36852626)

English

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine

scientific article published on June 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine (English)

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

anti-retroviral agent

0 references

1 reference

based on heuristic

inferred from title

41

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

36

object named as

Marc Lallemant

0 references

Nicole Ngo-Giang-Huong

18

object named as

Nicole Ngo-Giang-Huong

0 references

object named as

Maria Zolfo

48

0 references

Catherine Orrell

object named as

Catherine Orrell

43

0 references

Susan P. Holmes

object named as

Susan Holmes

5

0 references

Vincent C Marconi

object named as

Vincent C Marconi

38

0 references

object named as

Gert U van Zyl

15

0 references

object named as

Lutgarde Lynen

37

0 references

Kiat Ruxrungtham

11

object named as

Kiat Ruxrungtham

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Martine Peeters

20

object named as

Martine Peeters

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

30

object named as

Susan H Eshleman

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Charlotte Charpentier

26

object named as

Charlotte Charpentier

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Tobias F Rinke de Wit

8

object named as

Tobias F Rinke de Wit

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

4

object named as

Nathan Ford

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Giulia Cappelli

25

object named as

Giulia Cappelli

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

31

object named as

Joseph Fokam

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Phyllis J Kanki

10

object named as

Phyllis J Kanki

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

7

object named as

Raph L Hamers

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Mina C Hosseinipour

17

object named as

Mina C Hosseinipour

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Avelin F. Aghokeng

21

object named as

Avelin Aghokeng

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

2

object named as

Soo-Yon Rhee

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Robert W Shafer

50

object named as

Robert W Shafer

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Johnstone J Kumwenda

35

object named as

Johnstone J Kumwenda

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Carole L Wallis

13

object named as

Carole L Wallis

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

David Katzenstein

33

object named as

David Katzenstein

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Wendy S Stevens

14

object named as

Wendy Stevens

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

47

object named as

Davey Smith

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

27

object named as

Anoumou Y Dagnra

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Donato D Koyalta

34

object named as

Donato D Koyalta

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Kim C E Sigaloff

6

object named as

Kim C Sigaloff

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Silvia Bertagnolio

3

object named as

Silvia Bertagnolio

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Jonathan M Schapiro

44

object named as

Jonathan M Schapiro

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

1

object named as

Michele W Tang

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Torsak Bunupuradah

22

object named as

Torsak Bunupuradah

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

24

object named as

Patricia Cane

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

author name string

Herve J Fleury

9

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Claudia A Hawkins

12

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Weerawat Manosuthi

16

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Laurent Belec

19

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sherri Burda

23

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Alaka K Deshpande

28

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Ziad El-Katib

29

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Jean-Chrysostome Gody

32

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Nicolas A Margot

39

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sandrine Moussa

40

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Phillipe N Nyambi

42

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Rob Schuurman

45

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Sunee Sirivichayakul

46

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Michael R Jordan

49

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

language of work or name

0 references

publication date

1 June 2013

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Journal of Infectious Diseases

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

207 Suppl 2

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

S70-7

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

Rates of emergence of HIV drug resistance in resource-limited settings: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

Nucleic acid template and the risk of a PCR-Induced HIV-1 drug resistance mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

Virological follow-up of adult patients in antiretroviral treatment programmes in sub-Saharan Africa: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

jpHMM: improving the reliability of recombination prediction in HIV-1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

Class-sparing regimens for initial treatment of HIV-1 infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

HIV-1 subtype B protease and reverse transcriptase amino acid covariation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

The K65R mutation in human immunodeficiency virus type 1 reverse transcriptase exhibits bidirectional phenotypic antagonism with thymidine analog mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

An automated genotyping system for analysis of HIV-1 and other microbial sequences

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

Human immunodeficiency virus reverse transcriptase and protease sequence database

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

29 September 2017

Standardized comparison of the relative impacts of HIV-1 reverse transcriptase (RT) mutations on nucleoside RT inhibitor susceptibility

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

27 June 2018

Modulation of K65R selection by zidovudine inclusion: analysis of HIV resistance selection in subjects with virologic failure receiving once-daily abacavir/lamivudine/zidovudine and tenofovir DF (study COL40263).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

27 June 2018

Template usage is responsible for the preferential acquisition of the K65R reverse transcriptase mutation in subtype C variants of human immunodeficiency virus type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

27 June 2018

Intensification of a failing regimen with zidovudine may cause sustained virologic suppression in the presence of resensitising mutations including K65R.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

4 September 2018

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

4 September 2018

Genotypic and phenotypic predictors of the magnitude of response to tenofovir disoproxil fumarate treatment in antiretroviral-experienced patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

4 September 2018

Broad Nucleoside Reverse‐Transcriptase Inhibitor Cross‐Resistance in Human Immunodeficiency Virus Type 1 Clinical Isolates

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3657117

4 September 2018

Resistance development over 144 weeks in treatment-naive patients receiving tenofovir disoproxil fumarate or stavudine with lamivudine and efavirenz in Study 903

1 reference

https://pubmed.ncbi.nlm.nih.gov/23687292

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1093/INFDIS/JIT114

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

16 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36852626&oldid=2087583427"